Published in Br J Pharmacol on March 01, 1996
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES. J Histochem Cytochem (1964) 10.70
Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (1987) 8.89
Glutamate neurotoxicity and diseases of the nervous system. Neuron (1988) 8.26
Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science (1992) 6.49
Molecular diversity of glutamate receptors and implications for brain function. Science (1992) 4.90
A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem (1975) 4.29
Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol (1986) 3.18
Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci (1990) 2.95
Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature (1992) 2.18
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem (1989) 1.82
Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci U S A (1988) 1.38
Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett (1984) 1.29
Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J Neurosci (1994) 1.27
Excitotoxic models for neurodegenerative disorders. Life Sci (1984) 1.25
Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J Pharmacol Exp Ther (1983) 1.19
Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol (1990) 1.18
Quinolinic acid: regional variations in neuronal sensitivity. Brain Res (1983) 1.02
Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J Neurosci (1988) 1.01
Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience (1987) 0.91
A comparison of excitotoxic lesions of the basal forebrain by kainate, quinolinate, ibotenate, N-methyl-D-aspartate or quisqualate, and the effects on toxicity of 2-amino-5-phosphonovaleric acid and kynurenic acid in the rat. Br J Pharmacol (1991) 0.86
A comparison of the effects of quinolinate and N-methyl-aspartate on neurons in rat piriform cortex. Neurosci Lett (1986) 0.84
Organization and morphologies of acetylcholinesterase-containing neurons in the thalamus and hypothalamus of the rat. J Comp Neurol (1976) 0.82
Quinolinate differentiates between forebrain and cerebellar NMDA receptors. Eur J Pharmacol (1991) 0.80
Excitotoxic lesions of rat basal forebrain: differential effects on choline acetyltransferase in the cortex and amygdala. Neuroscience (1992) 0.79
Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat. Neurobiol Aging (1985) 0.78
Glycine-insensitive NMDA-sensitive receptor expressed in Xenopus oocytes by guinea pig cerebellar mRNA. J Neurosci (1990) 0.78
Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exp Ther (1976) 2.15
The role of dopamine in locomotor activity and learning. Brain Res (1983) 1.73
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. Am J Psychiatry (1997) 1.46
The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl) (1998) 1.22
Behavioral contrast in rats with different reinforcers and different response topographies. J Exp Anal Behav (1975) 1.11
Practice principles of cognitive enhancement therapy for schizophrenia. Schizophr Bull (1999) 1.10
Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. Am J Psychiatry (1997) 1.09
Developmental theory for a cognitive enhancement therapy of schizophrenia. Schizophr Bull (1999) 1.08
Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatry Neurol (1990) 0.99
Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation? Exp Brain Res (1993) 0.98
Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites. Brain Res (1990) 0.96
Interaction between the effects of pentobarbital and procaine in mice: the importance of timing in drug addition studies. Can J Physiol Pharmacol (1969) 0.96
Subfornical organ stimulation elicits drinking. Brain Res Bull (1995) 0.96
The acquisition of responding with conditioned reinforcement: effects of cocaine, (+)-amphetamine and pipradrol. Br J Pharmacol (1981) 0.95
The separation and partial purification of membrane-bound (Na + + K + )-dependent Mg 2+ -ATPase and (Na + +K + (Na + +K + )-independent Mg 2+ -ATPase from frog skeletal muscle. Biochim Biophys Acta (1970) 0.95
The effect of pimozide on the establishment of conditioned reinforcement. Psychopharmacology (Berl) (1980) 0.95
The effects of pipradrol on the acquisitionof responding with conditioned reinforcement: a role for sensory preconditioning. Psychopharmacology (Berl) (1980) 0.94
Increased rate of rapid axonal transport in vitamin E deficient rats. Brain Res (1975) 0.94
Personal therapy: a disorder-relevant psychotherapy for schizophrenia. Schizophr Bull (1995) 0.93
Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: modulation by inhibition of nitric oxide synthesis. Brain Res (1995) 0.92
Prepulse inhibition following lesions of the inferior colliculus: prepulse intensity functions. Physiol Behav (1998) 0.92
An exoglycosidase-sensitive triggering site on NK cells which is coupled to transmethylation of membrane phospholipids. J Immunol (1985) 0.91
Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol Biochem Behav (1993) 0.91
Stimulation of GABAB receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze. Brain Res (1994) 0.90
Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sci (1998) 0.89
Psychopharmacology of conditioned reward: evidence for a rewarding signal at D1-like dopamine receptors. Psychopharmacology (Berl) (1999) 0.89
Hippocampal-prefrontocortical circuits: PKA inhibition in the prefrontal cortex impairs delayed nonmatching in the radial maze in rats. Behav Neurosci (2001) 0.89
Cognitive remediation in schizophrenia: proceed ... with caution! Schizophr Bull (1992) 0.88
Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats. Psychopharmacology (Berl) (1987) 0.88
Dopaminergic substrates of cocaine-induced place conditioning. Brain Res (1986) 0.88
The use of conditioned suppression to evaluate the nature of neuroleptic-induced avoidance deficits. J Pharmacol Exp Ther (1980) 0.87
Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. Psychopharmacology (Berl) (1993) 0.87
The D1 dopamine receptor antagonist, SCH 23390 reduces locomotor activity and rearing in rats. Pharmacol Biochem Behav (1985) 0.86
Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making. Neurotox Res (2008) 0.86
Behavioural sensitization in addiction, schizophrenia, Parkinson's disease and dyskinesia. Neurotox Res (2006) 0.86
Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol Biochem Behav (1991) 0.85
The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward. Brain Res (1994) 0.85
Do neuroleptics impair learning in schizophrenic patients? Schizophr Res (1991) 0.85
The effects of pimozide during pairing on the transfer of classical conditioning to an operant discrimination. Pharmacol Biochem Behav (1981) 0.85
Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats. J Pharmacol Exp Ther (2010) 0.85
Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Prog Neurobiol (1990) 0.84
Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience (1997) 0.84
Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci Lett (1996) 0.84
Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. Eur J Pharmacol (1998) 0.84
Quinolinic acid neurotoxicity in the nucleus basalis antagonized by kynurenic acid. Neurobiol Aging (1985) 0.83
Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid. Br J Pharmacol (1998) 0.83
The use of extinction to investigate the nature of neuroleptic-induced avoidance deficits. Psychopharmacology (Berl) (1980) 0.83
Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats. Psychopharmacology (Berl) (1991) 0.83
The effects of (+)-amphetamine and apomorphine on responding for a conditioned reinforcer. Psychopharmacology (Berl) (1986) 0.83
Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science (1983) 0.82
Pimozide-induced suppression of responding: evidence against a block of food reward. Pharmacol Biochem Behav (1980) 0.82
Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol Biochem Behav (2000) 0.82
Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal. J Comp Neurol (1998) 0.82
Lack of recovery of cortical cholinergic function following quinolinic or ibotenic acid injections into the nucleus basalis magnocellularis in rats. Exp Neurol (1986) 0.82
Conditioned locomotion in rats following amphetamine infusion into the nucleus accumbens: blockade by coincident inhibition of protein kinase A. Behav Pharmacol (2000) 0.82
Too much of a good thing? Elevated baseline sleep spindles predict poor avoidance performance in rats. Brain Res (2010) 0.81
Biochemical and morphological characteristics of calcium uptake by denervated skeletal muscle. Exp Neurol (1982) 0.81
The neurotoxic actions of quinolinic acid in the central nervous system. Can J Physiol Pharmacol (1986) 0.81
Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol Biochem Behav (1988) 0.81
Comparison of immunoadsorbents prepared by coupling sperm-whale myoglobin to a variety of insoluble polymers. Biochem J (1970) 0.81
Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism. Behav Brain Res (1990) 0.81
Differential effects of scopolamine on working and reference memory of rats in the radial maze. Pharmacol Biochem Behav (1984) 0.81
Morphine releases endogenous adenosine from the spinal cord in vivo. Eur J Pharmacol (1987) 0.80
N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol. Brain Res (1992) 0.80
Rostral-caudal differences in effects of nucleus accumbens amphetamine on VTA ICSS. Brain Res (1994) 0.80
The neurosociology of schizophrenia: vulnerability and functional disability. Psychiatry (1995) 0.80
Coping, social support, and depressive symptoms in Parkinson's disease. J Geriatr Psychiatry Neurol (1990) 0.80
The effects of pimozide on the establishment of conditioned reinforcement as a function of the amount of conditioning. Psychopharmacology (Berl) (1985) 0.80
Activation of nitric oxide-synthesizing neurones during precipitated morphine withdrawal. Neuroreport (1996) 0.80
Ca2+-activated protease in denervated rat skeletal muscle measured by an immunoassay. Exp Neurol (1983) 0.80
Peripheral nerve contains heterogeneous growth factors that support sensory neurons in vitro. Neurosci Lett (1981) 0.80
Neurotoxicity of aluminum. Can J Physiol Pharmacol (1984) 0.80
Excitotoxic lesions of rat basal forebrain: differential effects on choline acetyltransferase in the cortex and amygdala. Neuroscience (1992) 0.79
Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience (1994) 0.79
Quisqualate lesions of rat NBM: selective effects on working memory in a double Y-maze. Brain Res Bull (1991) 0.79
Behavioral effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine. Pharmacol Biochem Behav (1991) 0.79
Capsaicin-sensitive nerves are required for glucostasis but not for catecholamine output during hypoglycemia in rats. Am J Physiol (1990) 0.79
Axonal transport of [3H]cholesterol derived from [3H]leucine in the sciatic nerve. FEBS Lett (1980) 0.79
Effects of inorganic anions on the contractility of vascular smooth muscle. Can J Physiol Pharmacol (1967) 0.79
Changes in rat muscle sarcoplasmic reticulum following neural application of batrachotoxin or tetrodotoxin. Exp Neurol (1980) 0.79
The D1 agonist SKF 38393 attenuates amphetamine-produced enhancement of responding for conditioned reward in rats. Pharmacol Biochem Behav (1995) 0.79
Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum. Brain Res (1994) 0.79
Animal studies of brain acetylcholine and memory. Arch Gerontol Geriatr Suppl (1989) 0.79
Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase. Neuropharmacology (1996) 0.78
Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol Biochem Behav (1986) 0.78